{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:45:24Z","timestamp":1760708724554,"version":"build-2065373602"},"reference-count":93,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T00:00:00Z","timestamp":1406764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.revmed.2014.04.004","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T11:00:22Z","timestamp":1407236422000},"page":"656-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Maladies auto-immunes et cancers. Deuxi\u00e8me partie\u00a0: maladies auto-immunes au cours des cancers et de leur traitement"],"prefix":"10.1016","volume":"35","author":[{"given":"F.","family":"Pasquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pavic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ninet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2014.04.004_bib0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.revmed.2007.10.416","article-title":"Cryoglobulin\u00e9mie","volume":"29","author":"Cacoub","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.revmed.2010.09.007","article-title":"Les syndromes neurologiques paran\u00e9oplasiques","volume":"32","author":"Didelot","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.revmed.2004.11.011","article-title":"Manifestations dysimmunitaires associ\u00e9es aux lymphomes","volume":"26","author":"Jardin","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0020","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.lpm.2007.03.035","article-title":"Diagnostic et prise en charge de l\u2019an\u00e9mie h\u00e9molytique auto-immune","volume":"36","author":"Philippe","year":"2007","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0248-8663(02)00688-4","article-title":"Caract\u00e9ristiques des an\u00e9mies h\u00e9molutiques auto-immunes de l\u2019adulte\u00a0: analyse r\u00e9trospective d\u2019une s\u00e9rie de 83\u00a0patients","volume":"23","author":"Genty","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0030","first-page":"235","article-title":"Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637\u00a0cases and comparison with myeloproliferative diseases","volume":"67","author":"D\u00fchrsen","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","article-title":"Angioimmunoblastic lymphadenopathy-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group","volume":"6","author":"Siegert","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.seminoncol.2006.01.011","article-title":"Autoimmune complications of chronic lymphocytic leukemia","volume":"33","author":"Hamblin","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.beha.2010.01.004","article-title":"Autoimmune complications in chronic lymphocytic leukaemia","volume":"23","author":"Zent","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0050","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1023\/A:1008319532359","article-title":"Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance","volume":"11","author":"Sallah","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jcp.45.12.1047","article-title":"The pathology of autoimmune haemolytic anaemia","volume":"45","author":"Sokol","year":"1992","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0060","first-page":"791","article-title":"Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia","volume":"7","author":"Sallah","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.revmed.2014.04.004_bib0065","first-page":"460","article-title":"Primary chronic cold agglutinin disease: a population based clinical study of 86\u00a0patients","volume":"91","author":"Berentsen","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2014.04.004_bib0070","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/1097-0142(197305)31:5<1092::AID-CNCR2820310509>3.0.CO;2-B","article-title":"Autoimmune disorders and malignant lymphoma","volume":"31","author":"Jones","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2014.04.004_bib0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.revmed.2010.04.005","article-title":"Neutrop\u00e9nie auto-immune","volume":"32","author":"Martin","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.revmed.2012.12.020","article-title":"Large granular lymphocyte leukemia: clinical and pathogenic aspects","volume":"34","author":"Lazaro","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1601-0825.2000.tb00115.x","article-title":"Paraneoplastic pemphigus: a review of the literature","volume":"6","author":"Allen","year":"2000","journal-title":"Oral Dis"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.revmed.2014.04.004_bib0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.revmed.2010.03.005","article-title":"Les angi\u0153d\u00e8mes bradykiniques acquis","volume":"31","author":"Fain","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2014.04.004_bib0100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01124-5","article-title":"Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2","volume":"113","author":"Fr\u00e9meaux-Bacchi","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.revmed.2011.12.005","article-title":"L\u2019angi\u0153d\u00e8me h\u00e9r\u00e9ditaire\u00a0: une r\u00e9volution th\u00e9rapeutique","volume":"33","author":"Bouillet","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1008389607293","article-title":"Guillain-Barr\u00e9 syndrome in a patient with non-Hodgkin's lymphoma","volume":"11","author":"Re","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0115","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/014107689408700915","article-title":"Effects of lymphoma on the peripheral nervous system","volume":"87","author":"Hughes","year":"1994","journal-title":"J R Soc Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0120","first-page":"292","article-title":"Myasthenia gravis and thymic Hodgkin's disease associated in one patient with familial lymphoproliferative disorders","volume":"13","author":"Padua","year":"1994","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/10428190109064612","article-title":"Myasthenia gravis and lymphoblastic lymphoma involving the thymus: a rare association","volume":"42","author":"Uner","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2014.04.004_bib0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0609.1983.tb01524.x","article-title":"A case of malignant lymphoma and myasthenia gravis","volume":"31","author":"Hansen","year":"1983","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0140","first-page":"9","article-title":"Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark","volume":"6","author":"Chow","year":"1995","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.revmed.2014.04.004_bib0145","first-page":"1855","article-title":"The overall and temporal association of cancer with polymyositis and dermatomyositis","volume":"21","author":"Zantos","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162\u00a0cases","volume":"83","author":"Dank\u00f3","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2014.04.004_bib0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2014.04.004_bib0160","first-page":"438","article-title":"Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study","volume":"35","author":"Andr\u00e1s","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005792-199405000-00004","article-title":"Ovarian cancer in patients with dermatomyositis","volume":"73","author":"Whitmore","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2014.04.004_bib0170","first-page":"219","article-title":"Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy","volume":"29","author":"Ang","year":"2000","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.revmed.2014.04.004_bib0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2014.04.004_bib0180","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40\u00a0patients","volume":"138","author":"Sparsa","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archderm.1990.01670290077012","article-title":"Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32\u00a0cases","volume":"126","author":"Basset-Seguin","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.revmed.2014.04.004_bib0195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0248-8663(98)80190-2","article-title":"Dermatopolymyosite et cancer\u00a0: \u00e9tude r\u00e9trospective de 12\u00a0cas parmi une cohorte de 50. \u00c9volution et facteurs pr\u00e9dictifs","volume":"19","author":"Batut","year":"1998","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0200","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.lpm.2010.06.008","article-title":"Comment faire le diagnostic et mieux comprendre les myopathies inflammatoires\u00a0? L\u2019utilit\u00e9 des auto-anticorps","volume":"39","author":"Sibilia","year":"2010","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of anti-p155\u00a0autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis","volume":"64","author":"Trallero-Aragu\u00e1s","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2014.04.004_bib0210","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2014.04.004_bib0220","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archderm.138.7.969","article-title":"When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer?","volume":"138","author":"Callen","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0225","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/BOR.0b013e32833f1075","article-title":"Malignancy and myositis: novel autoantibodies and new insights","volume":"22","author":"Selva-O\u2019Callaghan","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0230","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.revmed.2011.11.018","article-title":"Myopathies inflammatoires, myopathies n\u00e9crosantes auto-imunes, myopathies g\u00e9n\u00e9tiques de l\u2019adulte\u00a0: fronti\u00e8res diagnostiques","volume":"33","author":"Dimitri","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0235","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.50.3.764","article-title":"Paraneoplastic necrotizing myopathy: clinical and pathological features","volume":"50","author":"Levin","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2014.04.004_bib0240","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00328515","article-title":"Paraneoplastic necrotizing myopathy: a rare disorder to be differentiated from polymyositis","volume":"236","author":"Vossk\u00e4mper","year":"1989","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0245","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.23085","article-title":"Vasculitides associated with malignancies: analysis of sixty patients","volume":"57","author":"Fain","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2014.04.004_bib0250","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005792-198807000-00003","article-title":"Vasculitis associated with malignancy. Experience with 13\u00a0patients and literature review","volume":"67","author":"Greer","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2014.04.004_bib0255","first-page":"486","article-title":"Vascularites et n\u00e9oplasies\u00a0: 14\u00a0observations","volume":"142","author":"Fain","year":"1991","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.revmed.2014.04.004_bib0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0049-0172(95)80026-3","article-title":"Vasculitides in hairy cell leukemia","volume":"25","author":"Hasler","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2014.04.004_bib0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1521-6926(02)00085-3","article-title":"Clinical manifestations and infectious complications of hairy-cell leukaemia","volume":"16","author":"Kraut","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0270","first-page":"39","article-title":"Vasculitis associated with malignancy","volume":"4","author":"Mertz","year":"1992","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0275","series-title":"Trait\u00e9 des maladies et syndromes syst\u00e9miques","first-page":"825","article-title":"Vascularites des maladies malignes","author":"Fain","year":"2008"},{"key":"10.1016\/j.revmed.2014.04.004_bib0280","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/sarh.2001.27717","article-title":"Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia","volume":"31","author":"Hamidou","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2014.04.004_bib0285","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/1529-0131(200012)13:6<417::AID-ART13>3.0.CO;2-T","article-title":"Temporal concurrence of vasculitis and cancer: a report of 12\u00a0cases","volume":"13","author":"Hutson","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.revmed.2014.04.004_bib0290","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0248-8663(01)00367-8","article-title":"My\u00e9lodysplasies et maladies syst\u00e9miques. Une association non fortuite","volume":"22","author":"Berthier","year":"2001","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0295","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1468-3083.2004.01069.x","article-title":"Paraneoplastic vasculitis associated with multiple myeloma","volume":"18","author":"S\u00e1nchez","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(93)90128-C","article-title":"Cutaneous leukocytoclastic vasculitis and renal cancer: two cases","volume":"94","author":"Lacour","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0305","first-page":"386","article-title":"Cutaneous leukocytoclastic vasculitis in a patient with an adenocarcinoma of the colon","volume":"14","author":"Callen","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0310","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2796.1994.tb00862.x","article-title":"Systemic polyarteritis nodosa as the initial manifestation of a gastric adenocarcinoma","volume":"236","author":"Poveda","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0315","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/sarh.2000.6988","article-title":"Adult Henoch-Sch\u00f6nlein purpura associated with malignancy","volume":"29","author":"Pertuiset","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2014.04.004_bib0320","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0248-8663(96)80805-8","article-title":"Une polyarthrite paran\u00e9oplasique s\u00e9ropositive","volume":"16","author":"Olive","year":"1995","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0325","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0248-8663(05)81326-8","article-title":"Aspects actuels de la polyarthrite paran\u00e9oplasique","volume":"13","author":"Pfitzenmeyer","year":"1992","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0330","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/ard.2007.070086","article-title":"Characteristics and survival of 26\u00a0patients with paraneoplastic arthritis","volume":"67","author":"Morel","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2014.04.004_bib0335","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.revmed.2010.08.005","article-title":"Manifestations syst\u00e9miques et auto-immunes des syndromes my\u00e9lodysplasiques","volume":"32","author":"Fain","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/39.4.417","article-title":"Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study","volume":"39","author":"Hamidou","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2014.04.004_bib0345","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","article-title":"Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy","volume":"91","author":"Enright","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0350","first-page":"1208","article-title":"Myelodysplasia and relapsing polychondritis","volume":"22","author":"Piette","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0355","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-200105000-00003","article-title":"Dermatologic manifestations of relapsing polychondritis. A study of 200\u00a0cases at a single center","volume":"80","author":"Franc\u00e8s","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2014.04.004_bib0360","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0248-8663(96)80810-1","article-title":"Maladies syst\u00e9miques au cours des syndromes my\u00e9lodysplasiques","volume":"16","author":"Hebbar","year":"1995","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0365","first-page":"721","article-title":"Rheumatic manifestations in myelodysplastic syndromes","volume":"18","author":"Castro","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0370","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.revmed.2005.06.012","article-title":"Manifestations immunes associ\u00e9es aux syndromes my\u00e9lodysplasiques. \u00c9tude prospective de 40\u00a0patients","volume":"26","author":"Bouali","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0375","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7326\/0003-4819-104-1-74","article-title":"Relapsing polychondritis. Survival and predictive role of early disease manifestations","volume":"104","author":"Michet","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000046525","article-title":"Immunohematological findings in myelodysplastic syndrome","volume":"105","author":"Novaretti","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0385","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/1042819021000016186","article-title":"Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"43","author":"Saif","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2014.04.004_bib0390","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/10428190109097653","article-title":"Second primary tumors and immune phenomena after fludarabine or 2-chloro-2\u2032-deoxyadenosine treatment","volume":"40","author":"Van Den Neste","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2014.04.004_bib0395","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/oxfordjournals.ndt.a027155","article-title":"Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia","volume":"11","author":"Tisler","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2014.04.004_bib0400","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0399-8320(06)73320-6","article-title":"Oxaliplatin-induced immune thrombocytopenia","volume":"30","author":"Pavic","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0405","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.revmed.2012.05.002","article-title":"Coma of unknown cause in a 35-year-old man","volume":"33","author":"Gilardin","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.04.004_bib0410","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2141.2003.04385.x","article-title":"Delayed-onset neutropenia associated with rituximab therapy","volume":"121","author":"Chaiwatanatorn","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0415","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1056\/NEJM200306263482620","article-title":"Neutropenia in patients treated with rituximab","volume":"348","author":"Voog","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0420","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.beem.2009.07.004","article-title":"Interferon induced thyroiditis","volume":"23","author":"Tomer","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2014.04.004_bib0425","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ajh.22008","article-title":"Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: results of a retrospective case review","volume":"86","author":"Figaro","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2014.04.004_bib0430","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1080\/10428190701704613","article-title":"Lenalidomide-associated hypothyroidism","volume":"48","author":"Menon","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2014.04.004_bib0435","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0002-9343(01)01137-8","article-title":"Hypothyroidism in patients with multiple myeloma following treatment with thalidomide","volume":"112","author":"Badros","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0440","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/014107680409700914","article-title":"Severe hypothyroidism after thalidomide treatment","volume":"97","author":"de Savary","year":"2004","journal-title":"J R Soc Med"},{"key":"10.1016\/j.revmed.2014.04.004_bib0445","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ctrv.2003.12.003","article-title":"Radiotherapy-induced thyroid disorders","volume":"30","author":"Jereczek-Fossa","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.revmed.2014.04.004_bib0450","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bmt.1701409","article-title":"Autoreactive antibodies following autologous peripheral blood stem cell transplantation","volume":"22","author":"Ishikawa","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2014.04.004_bib0455","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.bmt.1702658","article-title":"Autoimmune thrombocytopenia following autologous hematopoietic cell transplantation: review of literature and treatment options","volume":"26","author":"Jillella","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2014.04.004_bib0460","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bmt.1704073","article-title":"Autoimmune thrombocytopenic purpura after autologous stem cell transplantation","volume":"32","author":"Hequet","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2014.04.004_bib0465","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.bmt.1703664","article-title":"Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation","volume":"30","author":"Imamura","year":"2002","journal-title":"Bone Marrow Transplant"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866314004524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866314004524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:37Z","timestamp":1759336417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866314004524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":93,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0248866314004524"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2014.04.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladies auto-immunes et cancers. Deuxi\u00e8me partie\u00a0: maladies auto-immunes au cours des cancers et de leur traitement","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2014.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}